Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade - PubMed (original) (raw)
. 2001 Mar 1;61(5):2085-91.
Affiliations
- PMID: 11280770
Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade
D F Calvisi et al. Cancer Res. 2001.
Abstract
Mutations affecting phosphorylation sites in the beta-catenin gene have been implicated in the development of human and rodent hepatocellular carcinomas (HCCs). To further investigate the involvement of this gene in hepatocarcinogenesis, we used several transgenic mouse models of hepatic tumors induced by overexpression of c-myc in the liver either alone or in combination with transforming growth factor (TGF) alpha or TGF-beta1. Activation of beta-catenin, as judged by the presence of mutations and/or nuclear translocation of the protein, was most frequent in liver tumors from c-myc (4/17; 23.5%) and c-myc/TGF-beta1 (6/18; 33.3%) transgenic mice. However, it was very rare in faster growing and histologically more aggressive HCCs developed in c-myc/TGF-alpha mice (1/20; 5%). Administration of diethylnitrosamine, phenobarbital, or 2-amino-3,8-diethylimidazo[4,5-f]quinoxaline did not significantly affect the occurrence of beta-catenin mutations. Notably, nuclear accumulation of beta-catenin was observed only in adenomas and highly differentiated carcinomas with eosinophilic phenotype. Furthermore, preneoplastic lesions with eosinophilic phenotype frequently displayed focal nuclear positivity, colocalized with areas of high proliferation. In contrast, basophilic and clear-cell foci, as well as pseudo-glandular and poorly differentiated HCCs, exhibited a normal or reduced membranous immunoreactivity for beta-catenin. These studies suggest that nuclear translocation of beta-catenin and activation of Wingless/Wnt signaling may represent an early event in liver carcinogenesis, providing a growth advantage in a subset of hepatic tumors with a more differentiated phenotype.
Similar articles
- Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
Calvisi DF, Ladu S, Factor VM, Thorgeirsson SS. Calvisi DF, et al. Carcinogenesis. 2004 Jun;25(6):901-8. doi: 10.1093/carcin/bgh083. Epub 2004 Jan 23. Carcinogenesis. 2004. PMID: 14742323 - Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS. Santoni-Rugiu E, et al. Am J Pathol. 1996 Aug;149(2):407-28. Am J Pathol. 1996. PMID: 8701981 Free PMC article. - Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
Calvisi DF, Thorgeirsson SS. Calvisi DF, et al. Toxicol Pathol. 2005;33(1):181-4. doi: 10.1080/01926230590522095. Toxicol Pathol. 2005. PMID: 15805070 Review. - Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
Kim Y, Sills RC, Houle CD. Kim Y, et al. Toxicol Pathol. 2005;33(1):175-80. doi: 10.1080/01926230590522130. Toxicol Pathol. 2005. PMID: 15805069 Review.
Cited by
- Specific features of ß-catenin-mutated hepatocellular carcinomas.
Dantzer C, Dif L, Vaché J, Basbous S, Billottet C, Moreau V. Dantzer C, et al. Br J Cancer. 2024 Sep 11. doi: 10.1038/s41416-024-02849-7. Online ahead of print. Br J Cancer. 2024. PMID: 39261716 Review. - Signaling pathways in liver cancer: pathogenesis and targeted therapy.
Xue Y, Ruan Y, Wang Y, Xiao P, Xu J. Xue Y, et al. Mol Biomed. 2024 May 31;5(1):20. doi: 10.1186/s43556-024-00184-0. Mol Biomed. 2024. PMID: 38816668 Free PMC article. Review. - Nuclear Expression of Pygo2 Correlates with Poorly Differentiated State Involving c-Myc, PCNA and Bcl9 in Myanmar Hepatocellular Carcinoma.
Htun MW, Shibata Y, Soe K, Koji T. Htun MW, et al. Acta Histochem Cytochem. 2021 Dec 24;54(6):195-206. doi: 10.1267/ahc.21-00090. Epub 2021 Dec 21. Acta Histochem Cytochem. 2021. PMID: 35023882 Free PMC article. - Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment.
Chen WS, Liang Y, Zong M, Liu JJ, Kaneko K, Hanley KL, Zhang K, Feng GS. Chen WS, et al. Cell Rep. 2021 Nov 9;37(6):109974. doi: 10.1016/j.celrep.2021.109974. Cell Rep. 2021. PMID: 34758313 Free PMC article. - Autophagic Inhibition of Caveolin-1 by Compound Phyllanthus urinaria L. Activates Ubiquitination and Proteasome Degradation of β-catenin to Suppress Metastasis of Hepatitis B-Associated Hepatocellular Carcinoma.
Huang D, Yang B, Yao Y, Liao M, Zhang Y, Zeng Y, Zhang F, Wang N, Tong G. Huang D, et al. Front Pharmacol. 2021 Jun 8;12:659325. doi: 10.3389/fphar.2021.659325. eCollection 2021. Front Pharmacol. 2021. PMID: 34168559 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous